THMO Research and Charts

THMO - ThermoGenesis Holdings Inc (Healthcare: Medical Devices)

Projected Earnings Date: 2024-07-30 (Delayed quote data 2025-01-06)

Last 0.00	Change ⇓ 0.00 (0.00%)	Volume 23
	Open 0.00	High 0.00	Low 0.00

8EMA (Daily) 0.00	40EMA (Daily) 0.01	50EMA (Daily) 0.02	STO (Daily) 0.000	MACD Hist (Daily) 0.004
8EMA (Weekly) 0.008	40EMA (Weekly) 0.25	50EMA (Weekly) 0.33	STO (Weekly) 0.000	MACD Hist (Weekly) 0.030


Company Profile
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.